Back to Results
First PageMeta Content
European Medicines Agency / Pharmaceuticals policy / Clinical research / Pharmaceutical industry / Research


Report from the CMDh meeting held on[removed]April 2013 CMDh outcomes on referrals pursuant to Article 107i of Directive[removed]EC Tetrazepam-containing medicinal products The CMDh, having considered the PRAC assessment r
Add to Reading List

Document Date: 2013-05-02 09:35:49


Open Document

File Size: 303,98 KB

Share Result on Facebook

City

Bonn / /

Company

CMDh / /

Country

Sweden / /

/

Event

Bankruptcy / Product Recall / Product Issues / Employment Change / Business Partnership / /

/

IndustryTerm

pharmaceutical form / fixed combination applications / repeat use applications / active substance applications / well-established use applications / category products / pharmaceutical forms / chemical substances / medicinal products / /

Organization

CMDh Working Party on Harmonisation / CMDh Secretariat / European Commission / CMDh Working Party on Harmonisation of SmPCs There / European Union / Working Party on Harmonisation of SmPCs There / Council of the European Union / /

Person

Christer Backman / Peter Bachmann / /

/

Position

Vice-chairperson / chairperson / chair / /

Product

Referred / /

ProgrammingLanguage

EC / /

PublishedMedium

the Best Practice Guide / the CMDh Best Practice Guide / /

Technology

jsp / http / /

URL

www.hma.eu/cmdh.html / http /

SocialTag